Talmadge, J. E. (2016). Genetically Engineered Multivalent Proteins for Targeted Immunotherapy. Clin Cancer Res.
Chicago Style CitationTalmadge, James E. "Genetically Engineered Multivalent Proteins for Targeted Immunotherapy." Clin Cancer Res 2016.
Cita MLATalmadge, James E. "Genetically Engineered Multivalent Proteins for Targeted Immunotherapy." Clin Cancer Res 2016.
Atenció: Aquestes cites poden no estar 100% correctes.